Accuray Incorporated Asset Resilience Ratio
Accuray Incorporated asset resilience ratio. Accuray Incorporated (ARAY) has an Asset Resilience Ratio of 3.32% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Accuray Incorporated (ARAY) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Accuray Incorporated (2005–2021)
Asset resilience ratio of Accuray Incorporated from 2005 to 2021. This chart shows how Accuray Incorporated's Asset Resilience Ratio has changed over time. Read debt load of Accuray Incorporated for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Accuray Incorporated's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Accuray Incorporated (ARAY) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $15.94 Million | 3.32% |
| Total Liquid Assets | $15.94 Million | 3.32% |
Asset Resilience Insights
- Limited Liquidity: Accuray Incorporated maintains only 3.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Accuray Incorporated Industry Peers by Asset Resilience Ratio
Compare Accuray Incorporated's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Accuray Incorporated Asset Resilience Ratio by Year (2005–2021)
Accuray Incorporated asset resilience ratio by year from 2005 to 2021. The table below shows the annual Asset Resilience Ratio data for Accuray Incorporated.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-06-30 | 3.32% | $15.94 Million | $480.10 Million | -- |
| 2018-06-30 | 0.00% | $0.00 | $378.73 Million | -- |
| 2017-06-30 | 5.88% | $23.91 Million | $406.46 Million | -4.19pp |
| 2016-06-30 | 10.07% | $47.24 Million | $469.03 Million | -3.61pp |
| 2015-06-30 | 13.68% | $64.31 Million | $469.97 Million | -2.38pp |
| 2014-06-30 | 16.07% | $79.55 Million | $495.19 Million | -5.17pp |
| 2013-06-30 | 21.24% | $101.08 Million | $475.93 Million | +20.91pp |
| 2012-06-30 | 0.33% | $1.56 Million | $473.17 Million | -0.37pp |
| 2011-06-30 | 0.70% | $3.17 Million | $455.78 Million | -37.26pp |
| 2010-06-30 | 37.95% | $99.88 Million | $263.18 Million | +14.40pp |
| 2009-06-30 | 23.56% | $64.63 Million | $274.39 Million | -5.44pp |
| 2008-06-30 | 28.99% | $85.54 Million | $295.00 Million | +28.99pp |
| 2006-06-30 | 0.00% | $1.00K | $138.62 Million | -0.18pp |
| 2005-06-30 | 0.18% | $158.00K | $86.86 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more